Vijaypd Ceutical (NSE:VIJAYPD) EBIT: ₹ Mil (TTM As of Mar. 2025)


NSE:VIJAYPD Vijaypd Ceutical Ltd NSE:VIJAYPD
14 GF Score
Price ₹82.90
! 2 Warning Signs
View Full Analysis

What is Vijaypd Ceutical EBIT?

Vijaypd Ceutical NSE:VIJAYPD -4.05% 14 EBIT is ₹ Mil as of Mar. 2025. GuruFocus rates NSE:VIJAYPD with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Vijaypd Ceutical's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2025 was ₹84 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Vijaypd Ceutical's annualized ROC % for the quarter that ended in Mar. 2025 was 13.63%. Vijaypd Ceutical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 27.39%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Vijaypd Ceutical  (NSE:VIJAYPD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Vijaypd Ceutical's annualized ROC % for the quarter that ended in Mar. 2025 is calculated as:

ROC % (Q: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Mar. 2025 ))/ count )
=79.217 * ( 1 - 26.47% )/( (337.563 + 517.359)/ 2 )
=58.2482601/427.461
=13.63 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=332.745 - 9.344 - ( 139.177 - max(0, 312.736 - 298.574+139.177))
=337.563

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=571.458 - 23.089 - ( 31.01 - max(0, 244.563 - 464.032+31.01))
=517.359

Note: The Operating Income data used here is one times the annual (Mar. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Vijaypd Ceutical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Mar. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=83.927/( ( (24.292 + max(139.17, 0)) + (47.444 + max(401.936, 0)) )/ 2 )
=83.927/( ( 163.462 + 449.38 )/ 2 )
=83.927/306.421
=27.39 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(111.051 + 41.13 + 7.216) - (9.344 + 0 + 10.883)
=139.17

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(237.975 + 115.366 + 79.681) - (23.089 + 0 + 7.997)
=401.936

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Vijaypd Ceutical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2025 )
=/1805.647
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vijaypd Ceutical EBIT Related Terms

Vijaypd Ceutical EBIT Historical Data

* Premium members only.

The historical data trend for Vijaypd Ceutical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vijaypd Ceutical EBIT Chart

Vijaypd Ceutical Annual Data
Trend Mar23 Mar24 Mar25
EBIT
26.30 45.10 83.93

Vijaypd Ceutical Semi-Annual Data
Mar23 Mar24 Mar25
EBIT 26.30 45.10 83.93

Vijaypd Ceutical EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, Vijaypd Ceutical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vijaypd Ceutical EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vijaypd Ceutical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vijaypd Ceutical's EV-to-EBIT falls into.


NSE:VIJAYPD
14GF Score
Vijaypd Ceutical Ltd NSE:VIJAYPD
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vijaypd Ceutical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹ Mil mean?
Vijaypd Ceutical (NSE:VIJAYPD) has a EBIT of ₹ Mil as of Mar. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vijaypd Ceutical.
Is Vijaypd Ceutical's EBIT too high?
Vijaypd Ceutical's current EBIT is ₹ Mil. Overall, Vijaypd Ceutical has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vijaypd Ceutical's EBIT compare to competitors?
Vijaypd Ceutical's EBIT of ₹ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vijaypd Ceutical. Vijaypd Ceutical's current EBIT is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaypd Ceutical stock overvalued right now?
Vijaypd Ceutical (NSE:VIJAYPD) has a current EBIT of ₹ Mil. The current EBIT is ₹ Mil. Vijaypd Ceutical's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Vijaypd Ceutical (NSE:VIJAYPD), the current EBIT is ₹ Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vijaypd Ceutical Business Description

Address A/1, 1st Floor, Devraj Premises, CHSL, Goregaon West, Mumbai, MH, IND, 400062
Vijaypd Ceutical Ltd is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. The company offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits.
14GF Score

Get the complete analysis for NSE:VIJAYPD

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹82.90
Price